Use of Translational Biomarkers in Pulmonary Fibrosis

PRO-C6 as a pharmacodynamic biomarker

During the development of pulmonary fibrosis, there are changes in the extracellular matrix. We see the destruction of the basement membrane and the formation of various collagens in the interstitial matrix.

We can monitor these changes in the ECM in a blood sample using Protein Fingerprint biomarker technology.

Watch more videos about the extracellular matrix and the Protein Fingerprint on our YouTube channel!

Get in touch

Are you interested in exploring collaboration possibilities?
Enter your information in the form and a representative will contact you shortly.

+45 4452 5252 Contact us via email!

Your scientific area Select areaCardiologyDermatologyGastroenterologyHepatologyNephrologyNeurologyObesityPulmonologyRheumatologyMulti-organ/Other Your request Select requestGeneral inquiryBiomarkersLaboratorySomething else

First name Last name

Email Phone (optional) Your message (optional) Nordic Bioscience ApS and its non-profit partner, The Extracellular Matrix Pharmacology Congress, can contact me by email with news on research, events, products, and similar. I can always withdraw my consent at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.